What is a Patient Information Leaflet and why is it useful?

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL17780/0743 .


Darunavir Zentiva 400mg & 800mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER

Darunavir 400 mg film-coated tablets

Darunavir 800 mg film-coated tablets

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet (see section 4).

What is in this leaflet:

1. What darunavir is and what it is used for
2. What you need to know before you take darunavir
3. How to take darunavir
4. Possible side effects
5. How to store darunavir
6. Contents of the pack and other information

1. WHAT DARUNAVIR IS AND WHAT IT IS USED FOR

Darunavir contains the active substance darunavir. Darunavir is an antiretroviral medicine used in the treatment of human immunodeficiency virus (HIV) infection. It belongs to a group of medicines called protease inhibitors. Darunavir works by reducing the amount of HIV in your body. This will improve your immune system and reduces the risk of developing illnesses linked to HIV infection.

The darunavir 400mg/800mg tablet is used to treat adults and children 3 years of age and above, and at least 40 kg body weight, who are infected by HIV and

  • who have not used antiretroviral medicines before.
  • in certain patients who have used antiretroviral medicines before (your doctor will determine this).

Darunavir must be taken in combination with a low dose of cobicistat or ritonavir and other anti-HIV medicines. Your doctor will discuss with you which combination of medicines is best for you.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DARUNAVIR

Do not take darunavir:

  • if you are allergic to darunavir or any of the other ingredients of this medicine (listed in section 6) or to ritonavir.
  • if you have severe liver problems. Ask your doctor if you are unsure about the severity of your liver disease. Some additional tests might be necessary.

Do not combine darunavir with any of the following medicines

If you are taking any of these, ask your doctor about switching to another medicine.

  • Avanafil (to treat erectile dysfunction).
  • Astemizole or terfenadine (to treat allergy symptoms).
  • Triazolam and oral (taken by mouth) midazolam (to help you sleep and/or relieve anxiety).
  • Cisapride (to treat some stomach conditions).
  • Colchicine (if you have kidney and/or liver problems; to treat gout or familial Mediterranean fever).
  • Lurasidone, pimozide, quetiapine or sertindole (to treat psychiatric conditions).
  • Ergot alkaloids like ergotamine, dihydroergotamine, ergometrine and methylergonovine (to treat migraine headaches).
  • Amiodarone, bepridil, dronedarone, ivabradine, quinidine, ranolazine (to treat certain heart disorders e.g. abnormal heart beat).
  • Lovastatin, simvastatin or lomitapide (to lower cholesterol levels).
  • Rifampicin (to treat some infections such as tuberculosis).
  • The combination product lopinavir/ritonavir (this anti-HIV medicine belongs to the same class as darunavir).
  • Elbasvir/grazoprevir (to treat hepatitis C infection).
  • Alfuzosin (to treat enlarged prostate).
  • Sildenafil (to treat high blood pressure in the pulmonary circulation).
  • Dabigatran, ticagrelor (to help stop the clumping of platelets in the treatment of patients with a history of a heart attack).
  • Naloxegol (to treat opioid induced constipation).
  • Dapoxetine (to treat premature ejaculation).
  • Domperidone (to treat nausea and vomiting).

Do not combine darunavir with products that contain St. John’s wort (Hypericum perforatum).

Warnings and precautions

Talk to your doctor or pharmacist before taking darunavir.

Darunavir is not a cure for HIV infection. You can still pass on HIV when taking this medicine, although the risk is lowered by effective antiretroviral therapy. Discuss with your physician the precautions needed to avoid infecting other people.

People taking darunavir may still develop infections or other illnesses associated with HIV infection. You must keep in regular contact with your doctor.

People taking darunavir may develop a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome) or a more severe form of rash causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis). Infrequently a rash may become severe or potentially life-threatening. Please contact your doctor whenever you develop a rash.

In patients taking darunavir and raltegravir (for HIV infection), rashes (generally mild or moderate) may occur more frequently than in patients taking either medicine separately.

Tell your doctor about your situation BEFORE and DURING your treatment

Make sure that you check the following points and tell your doctor if any of these apply to you.

  • Tell your doctor if you have had problems with your liver before, including hepatitis B and C infection. Your doctor may evaluate how severe your liver disease is before deciding if you can take darunavir.
  • Tell your doctor if you have diabetes. Darunavir might increase sugar levels in the blood.
  • Tell your doctor immediately if you notice any symptoms of infection (for example enlarged lymph nodes and fever). In some patients with advanced HIV infection and a history of opportunistic infection, signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started. It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
  • In addition to the opportunistic infections, autoimmune disorders (a condition that occurs when the immune system attacks healthy body tissue) may also occur after you start taking medicines for the treatment of your HIV infection. Autoimmune disorders may occur many months after the start of treatment. If you notice any symptoms of infection or other symptoms such as muscle weakness, weakness beginning in the hands and feet and moving up towards the trunk of the body, palpitations, tremor or hyperactivity, please inform your doctor immediately to seek necessary treatment.
  • Tell your doctor if you have haemophilia. Darunavir might increase the risk of bleeding.
  • Tell your doctor if you are allergic to sulphonamides (e.g. used to treat certain infections).
  • Tell your doctor if you notice any musculoskeletal problems. Some patients taking combination antiretroviral therapy may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone). The length of combination antiretroviral therapy, corticosteroid use, alcohol consumption, severe immunosuppression, higher body mass index, among others, may be some of the many risk factors for developing this disease. Signs of osteonecrosis are joint stiffness, aches and pains (especially of the hip, knee and shoulder) and difficulty in movement. If you notice any of these symptoms please inform your doctor.

Elderly

Darunavir has only been used in limited numbers of patients 65 years or older. If you belong to this age group, please discuss with your doctor if you can use darunavir.

Children

The darunavir 400mg/800mg tablet is not for use in children younger than 3 years of age or weighing less than 40 kg.

Other medicines and darunavir

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

There are some medicines that you must not combine with darunavir. These are mentioned above under the heading “Do not combine darunavir with any of the following medicines”.

In most cases, darunavir can be combined with anti-HIV medicines belonging to another class [e.g. NRTIs (nucleoside reverse transcriptase inhibitors), NNRTIs (non-nucleoside reverse transcriptase inhibitors), CCR5 antagonists and FIs (fusion inhibitors)]. Darunavir with ritonavir has not been tested with all PIs (protease inhibitors) and must not be used with other HIV PIs. In some cases dosage of other medicines might need to be changed. Therefore always tell your doctor if you take other anti-HIV medicines and follow your doctor’s instruction carefully on which medicines can be combined.

The effects of darunavir might be reduced if you take any of the following products. Tell your doctor if you take:

  • Phenobarbital, phenytoin (to prevent seizures)
  • Dexamethasone (corticosteroid)
  • Efavirenz (HIV infection)
  • Rifapentine, rifabutin (medicines to treat some infections such as tuberculosis)
  • Saquinavir (HIV infection).

The effects of other medicines might be influenced if you take darunavir. Tell your doctor if you take:

  • Amlodipine, diltiazem, disopyramide, carvedilol, felodipine, flecainide, lidocaine, metoprolol, mexiletine, nifedipine, nicardipine, propafenone, timolol, verapamil (for heart disease) as the therapeutic effect or side effects of these medicines may be increased.
  • Apixaban, edoxaban, rivaroxaban, warfarin, clopidogrel (to reduce clotting of the blood) as their therapeutic effect or side effects may be altered; your doctor may have to check your blood.
  • Oestrogen-based hormonal contraceptives and hormonal replacement therapy. Darunavir might reduce its effectiveness. When used for birth control, alternative methods of non-hormonal contraception are recommended.
  • Ethinylestradiol/drospirenone. Darunavir might increase the risk for elevated potassium levels by drospirenone.
  • Atorvastatin, pravastatin, rosuvastatin (to lower cholesterol levels). The risk of muscle damage might be increased. Your doctor will evaluate which cholesterol lowering regimen is best for your specific situation.
  • Clarithromycin (antibiotic).
  • Ciclosporin, everolimus, tacrolimus, sirolimus (for dampening down your immune system) as the therapeutic effect or side effects of these medicines might be increased. Your doctor might want to do some additional tests.
  • Corticosteroids including betametasone, budesonide, fluticasone, mometasone, prednisone, triamcinolone. These medicines are used to treat allergies, asthma, inflammatory bowel diseases, inflammatory conditions of the eyes, joints and muscles and other inflammatory conditions. If alternatives cannot be used, its use should only take place after medical evaluation and under close monitoring by your doctor for corticosteroid side effects.
  • Buprenorphine/naloxone (medicines to treat opiate dependence).
  • Salmeterol (medicine to treat asthma).
  • Artemether/lumefantrine (a combination medicine to treat malaria).
  • Dasatinib, everolimus, irinotecan, nilotinib, vinblastine, vincristine (to treat cancer).
  • Sildenafil, tadalafil, vardenafil (for erectile dysfunction or to treat a heart and lung disorder called pulmonary arterial hypertension).
  • Glecaprevir/pibrentasvir (to treat hepatitis C infection)
  • Fentanyl, oxycodone, tramadol (to treat pain)
  • Fesoterodine, solifenacin (to treat urologic disorders).

The dosage of other medicines might need to be changed since either their own or therapeutic effect of darunavir or side effects may be influenced when combined. Tell your doctor if you take:

  • Alfentanil (injectable strong and short-acting painkiller that is used for surgical procedures).
  • Digoxin (to treat certain heart disorders).
  • Clarithromycin (antibiotic).
  • Itraconazole, isavuconazole, fluconazole, posaconazole, clotrimazole (to treat fungal infections). Voriconazole should only be taken after medical evaluation.
  • Rifabutin (against bacterial infections).
  • Sildenafil, vardenafil, tadalafil (for erectile dysfunction or high blood pressure in the pulmonary circulation).
  • Amitriptyline, desipramine, imipramine, nortriptyline, paroxetine, sertraline, trazodone (to treat depression and anxiety).
  • Maraviroc (to treat HIV infection).
  • Methadone (to treat opiate dependence).
  • Carbamazepine, clonazepam (to prevent seizures or to treat certain types of nerve pain).
  • Colchicine (to treat gout or familial Mediterranean fever).
  • Bosentan (to treat high blood pressure in the pulmonary circulation).
  • Buspirone, clorazepate, diazepam, estazolam, flurazepam, midazolam when used as an injection zolpidem (sedative agents).
  • Perphenazine, risperidone, thioridazine (to treat psychiatric conditions).
  • Metformin (to treat type 2 diabetes).

This is not a complete list of medicines, tell your healthcare provider about all medicines that you are taking.

Darunavir with food and drink

See section 3 “How to take darunavir”.

Pregnancy and breast-feeding

Tell your doctor immediately if you are pregnant, planning to become pregnant or if you are breast-feeding. Pregnant or breast-feeding mothers should not take darunavir with ritonavir unless specifically directed by the doctor. Pregnant or breast-feeding mothers should not take darunavir with cobicistat. It is recommended that HIV infected women must not breast-feed their infants because of both the possibility of your baby becoming infected with HIV through your breast milk and because of the unknown effects of the medicine on your baby.

Driving and using machines

Do not operate machines or drive if you feel dizzy after taking darunavir.

Darunavir contains sodium.

This medicine contains less than 1 mmol sodium (23 mg) per tablet that is to say essentially “sodium free”.

Darunavir 400mg film-coated tablets contains sunset yellow FCF (E110)

It may cause allergic reactions

Darunavir 800 mg film-coated tablets contains ponceau 4R red (E124)

It may cause allergic reactions.

3. HOW TO TAKE DARUNAVIR

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Even if you feel better, do not stop taking darunavir and ritonavir without talking to your doctor.

After therapy has been initiated, the dose or dosage form must not be changed or therapy must not be stopped without instruction of the doctor.

Darunavir 400 mg film-coated tablets:

Darunavir 400 mg is only to be used to construct the once daily 800 mg regimen.

Darunavir 800 mg film-coated tablets:

Darunavir 800 mg is intended for once daily use only.

Dose for adults who have not taken antiretroviral medicines before (your doctor will determine this)

The usual dose of darunavir is 800 mg (2 tablets of darunavir containing 400 mg darunavir or 1 tablet of darunavir containing 800 mg darunavir) once daily.

You must take darunavir every day and always in combination with 150 mg of cobicistat or 100 mg of ritonavir and with food. Darunavir cannot work properly without ritonavir and food. You must eat a meal or a snack within 30 minutes prior to taking your darunavir and ritonavir. The type of food is not important. Even if you feel better, do not stop taking darunavir and ritonavir without talking to your doctor.

Instructions for adults

Darunavir 400 mg film-coated tablets:

  • Take two 400 mg tablets at the same time, once a day, every day.

Darunavir 800 mg film-coated tablets:

  • Take one 800 mg tablet at the same time, once a day, every day.
  • Always take darunavir together with 150 mg of cobicistat or 100 mg of ritonavir.
  • Take darunavir with food.
  • Swallow the tablets with a drink such as water or milk.
  • Take your other HIV medicines used in combination with darunavir and cobicistat or ritonavir as recommended by your doctor.
  • Oral suspension containing darunavir has been developed for use in children, but in some cases, can also be used in adults.

Dose for adults who have taken antiretroviral medicines before (your doctor will determine this)

The dose is either:

  • 800 mg darunavir (2 tablets of darunavir containing 400 mg darunavir or 1 tablet of darunavir containing 800 mg darunavir) together with 150 mg cobicistat or 100 mg ritonavir once daily.

OR

  • 600 mg darunavir (1 tablet of darunavir containing 600 mg darunavir) together with 100 mg ritonavir twice daily.

Please discuss with your doctor which dose is right for you.

Dose for children of 3 years of age and above with ritonavir, and 12 years of age and above with cobicistat, weighing more than 40 kg who have not taken antiretroviral medicines before (your child’s doctor will determine this)

  • The usual dose of darunavir is 800 mg (2 tablets of darunavir containing 400 mg darunavir or 1 tablet of darunavir containing 800 mg darunavir) together 100 mg ritonavir or 150 mg of cobicistat once daily.

Dose for children 3 years of age and above with ritonavir, and 12 years of age and above with cobicistat, weighing more than 40 kg who have taken antiretroviral medicines before (your child’s doctor will determine this)

The dose is:

  • 800 mg darunavir (2 tablets of darunavir containing 400 mg darunavir or 1 tablet of darunavir containing 800 mg darunavir) with 100 mg ritonavir or 150 mg of cobicistat once daily.

OR

  • 600 mg darunavir (1 tablet of darunavir containing 600 mg darunavir) together with 100 mg ritonavir twice daily.

Please discuss with your doctor which dose is right for you.

Instructions for children 3 years of age and above with ritonavir, and 12 years of age and above with cobicistat, weighing more than 40 kg

  • Take 800 mg darunavir (2 tablets of darunavir containing 400 mg darunavir or 1 tablet of darunavir containing 800 mg darunavir) at the same time, once a day, every day.
  • Take darunavir always together with 100 mg of ritonavir or 150 mg of cobicistat.
  • Take darunavir with food.
  • Swallow the tablets with a drink such as water or milk.
  • Take your other HIV medicines used in combination with darunavir and ritonavir or cobicistat as recommended by your doctor.

Removing the child resistant cap

The plastic bottle comes with a child resistant cap and must be opened as follows:

  • Push the plastic screw cap down while turning it counter clockwise.
  • Remove the unscrewed cap.

If you take more darunavir than you should

Contact your doctor, pharmacist or nurse immediately.

If you forget to take darunavir

If you notice within 12 hours, you must take the tablets immediately. Always take with ritonavir and food. If you notice after 12 hours, then skip the intake and take the next doses as usual. Do not take a double dose to make up for a forgotten dose.

If you vomit after taking darunavir and cobicistat or ritonavir

If you vomit within 4 hours of taking the medicine, another dose of darunavir and cobicistat or ritonavir should be taken with food as soon as possible. If you vomit more than 4 hours after taking the medicine, then you do not need to take another dose of darunavir and cobicistat or ritonavir until the next regularly scheduled time.

Contact your doctor if you are uncertain about what to do if you miss a dose or vomit.

Do not stop taking darunavir without talking to your doctor first

Anti-HIV medicines may make you feel better. Even when you feel better, do not stop taking darunavir. Talk to your doctor first.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist.

4. POSSIBLE SIDE EFFECTS

During HIV therapy there may be an increase in weight and in levels of blood lipids and glucose. This is partly linked to restored health and life style, and in the case of blood lipids sometimes to the HIV medicines themselves. Your doctor will test for these changes.

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor if you develop any of the following side effects

  • A reaction called DRESS [severe rash, which may be accompanied by fever, fatigue, swelling of the face or lymph glands, increase of eosinophils (type of white blood cells), effects on liver, kidney or lung].
  • Severe skin reactions (Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis), causing flu like symptoms, (cough, runny nose, fever, decreased appetite and malaise) and skin rashes which may develop into blisters and peeling skin; a widespread rash with blisters and peeling skin, particularly around the mouth, nose and genitals (Stevens-Johnson syndrome) or a more severe form of rash causing skin peeling in more than 30% of the body surface.
  • Liver problems that may occasionally be severe have been reported. Your doctor should do blood tests before you start darunavir. If you have chronic hepatitis B or C infection, your doctor should check your blood tests more often because you have an increased chance of developing liver problems. Talk to your doctor about the signs and symptoms of liver problems. These may include yellowing of your skin or whites of your eyes, dark (tea coloured) urine, pale coloured stools (bowel movements), nausea, vomiting, loss of appetite, or pain, aching, and discomfort on your right side below your ribs.
  • Skin rash (more often when used in combination with raltegravir), itching. The rash is usually mild to moderate. A skin rash might also be a symptom of a rare severe situation. It is therefore important to contact your doctor if you develop a rash. Your doctor will advise you how to deal with your symptoms or whether darunavir must be stopped.
  • Other severe side effects were diabetes (common) and inflammation of the pancreas (uncommon). Symptoms of inflammation of the pancreas include severe stomach pain, which may reach through to your back.

Very common side effects (may affect more than 1 in 10 people):

  • Diarrhoea.

Common side effects (may affect up to 1 in 10 people):

  • Vomiting, nausea, abdominal pain or distension, dyspepsia, flatulence.
  • Headache, tiredness, dizziness, drowsiness, numbness, tingling or pain in hands or feet, loss of strength, difficulty falling asleep.

Uncommon side effects (may affect up to 1 in 100 people):

  • Chest pain, changes in electrocardiogram, rapid heart beating.
  • Decreased or abnormal skin sensitivity, pins and needles, attention disturbance, loss of memory, problems with your balance.
  • Difficulty breathing, cough, nosebleed, throat irritation.
  • Inflammation of the stomach or mouth, heartburn, retching, dry mouth, discomfort of the abdomen, constipation, belching.
  • Kidney failure, kidney stones, difficult discharge of urine, frequent or excessive passage of urine, sometimes at night.
  • Urticaria, severe swelling of the skin and other tissues (most often the lips or the eyes), eczema, excessive sweating, night sweats, hair loss, acne, scaly skin, colouration of nails.
  • Muscle pain, muscle cramps or weakness, pain in extremities osteoporosis.
  • Slowing down of the thyroid gland function. This can be seen in a blood test.
  • High blood pressure, flushing.
  • Red or dry eyes.
  • Fever, swelling of lower limbs due to fluids, malaise, irritability, pain.
  • Symptoms of infection, herpes simplex.
  • Erectile dysfunction, enlargement of breasts.
  • Sleeping problems, sleepiness, depression, anxiety, abnormal dreams, decrease in sexual drive.

Rare side effects (may affect up to 1 in 1,000 people):

  • Heart attack, slow heart beating, palpitations.
  • Visual disturbance.
  • Chills, feeling abnormal.
  • A feeling of confusion or disorientation, altered mood, restlessness.
  • Fainting, epileptic fits, changes or loss of taste.
  • Mouth sores, vomiting blood, inflammation of the lips, dry lips, coated tongue.
  • Running nose.
  • Skin lesions, dry skin.
  • Stiffness of muscles or joints, joint pain with or without inflammation.
  • Changes in some values of your blood cells or chemistry. These can be seen in the results of blood and/or urine tests. Your doctor will explain these to you. Examples are: increase in some white blood cells.

Some side effects are typical for anti-HIV medicines in the same family as darunavir. These are:

  • Muscle pain, tenderness or weakness. On rare occasions, these muscle disorders have been serious.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE DARUNAVIR

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the bottle after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What darunavir contains:

  • The active substance is darunavir. Each tablet contains 400mg or 800 mg of darunavir.

Darunavir 400 mg film-coated tablets:

The other ingredients are: dry granulation agent (mixture of microcrystalline cellulose and anhydrous calcium hydrogen phosphate), croscarmellose sodium, microcrystalline cellulose, colloidal anhydrous silica, magnesium stearate, Opadry II Orange 85F23836 [mixture of poly(vinyl alcohol) – partially hydrolysed, titanium dioxide (E171), macrogol 3350, talc and sunset yellow FCF aluminium lake (E110)].

Darunavir 800 mg film-coated tablets:

The other ingredients are: dry granulation agent (mixture of microcrystalline cellulose and anhydrous calcium phosphate), croscarmellose sodium, microcrystalline cellulose, colloidal anhydrous silica, magnesium stearate, Opadry II Brown 85F265048 [mixture of poly(vinyl alcohol) – partially hydrolysed, titanium dioxide (E171), macrogol 3350, talc, Ponceau 4R aluminium lake (E124), red iron oxide (E172) and yellow iron oxide (E172)].

What darunavir looks like and contents of the pack:

Darunavir 400 mg film-coated tablets:

Plain, oval, biconvex, light orange film-coated tablets of approx. 19 mm length and 10 mm width. 60 film-coated tablets in HDPE bottle with child-resistant screw cap.

Darunavir 800 mg film-coated tablets:

Plain, oval, biconvex, dark red film-coated tablets of approx. 20 mm length and 10 mm width.

30 film-coated tablets in HDPE bottle with child-resistant screw cap.

Bundle pack of 2 HDPE bottles with 30 film-coated tablets in each bottle.

Darunavir is also available as 75, 150, 400 and 600 mg film-coated tablets.

Not all pack sizes may be marketed.

The Marketing Authorisation Holder is

Zentiva Pharma UK Limited
12 New Fetter Lane
London
EC4A 1JP
UK

The manufacturer is

Zentiva, k. s.
U kabelovny 130
Dolní Měcholupy
102 37 Prague
Czech Republic

Or

S.C. Zentiva S.A.
B-dul Theodor Pallady nr. 50
sector 3 Bucuresti
Cod – 032266
Romania

This leaflet was last updated in June 2021

799045

1065023588